The President’s Health Adviser: New Corona treatment reduces hospitalizations and the risk of death

Dr. Mohamed Awad Taj El-Din, Adviser to the President for Health and Preventive Affairs, confirmed that the drug Corona The new one, which will be presented in the Egyptian market, has proven to be effective and will be put on the market for emergency use, according to controls determined by doctors and disbursed from hospitals, explaining that this drug is used in simple to moderate cases infected with Corona.

Dr. Muhammad Awad Taj El-Din added, during a telephone interview on the “Cairo Talk” program with the media, Charity Ramadan and Karima Awad, on Al-Qahera Wal-Nas channel, that the new Corona drug is taken orally and dosed for 5 days, and the condition for use is that the case is infected with another disease beside Corona. .

He continued, “This drug was produced by two international companies, and thanks to our doctors, we were able to take approval for the production of this drug in Egypt, and in five companies that produce this drug in Egypt, and this drug contributes to reducing the risk of corona, and the two main benefits are that it reduces hospital admission rates and reduces the possibility of death.” And this medicine is an emergency record and quickly, and this registration requires that it be present in hospitals, and the patient is treated at the hospital.”

Share:

Facebook
Twitter
Pinterest
LinkedIn

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.